Female Infertility
91
17
18
42
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.3%
3 terminated out of 91 trials
93.3%
+6.8% vs benchmark
24%
22 trials in Phase 3/4
7%
3 of 42 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 42 completed trials
Clinical Trials (91)
A Clinical Trial to Evaluate the Effects of a Supplement on Markers of Female Fertility
Mobile Health Support Before Oocyte Pick-Up in Infertile Women
Progesterone Luteal Support in Unexplained Infertility Management
Effect of Comprehensive Spa Rehabilitation on Female Infertility: A Clinical Study in Adult Women (Infertility-Spa)
Autologous Ovarian Tissue Transplantation
Intrauterine G-CSF Infusion for Thin Endometrium
Uterine Transplant in Absolute Uterine Infertility (AUIF)
Hippo-Related Competing Endogenous RNA (ceRNA) Network Dysregulation and In Vitro Fertilization (IVF) Outcomes in Women With Diminished Ovarian Reserve
Clinical Relevance of Modifying RANKL Signaling During Folliculogenesis
Endometrial Immune Profile Changes After Autologous Intrauterine PRP Treatment
Magnetic Resonance Imaging (MRI) Hysterosalpingography Versus Radiographic Hysterosalpingography in Female Infertility
Day-4 Embryo Defragmentation: Blastocyst Rate and clInical Outcomes
Detection of Microplastics in Human Granulosa Cells and in the Follicular Fluid of Women Undergoing ICSI Treatment
Establishing a Minimum Predictive Threshold Follicular Size and Oocyte Retrieval in ICSI Cycle
Comparison of IVF Outcomes Between PPOS and Antagonist Protocols in Women With PCOS
Vaginal Estradiol and Oral Guaifenesin in Clomiphene Ovulation Induction
Biobank Aimed to Study Gynecological Pathologies, of Male and Female Infertility and Pregnancy Pathologies
Effects of Intrauterine Flushing With Human Chorionic Gonadotropin on ICSI Outcome
Prospective Validation Study of a Uterine Fibroid-Related Infertility Prediction Model
Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism